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Summary
In the DSM-5 a new “tic-related” specifier for obsessive compulsive disorder (OCD) has 
been introduced, highlighting the importance of an accurate characterization of patients 
suffering from obsessive-compulsive tic-related disorder (“OCTD”). In order to character-
ize OCTD from a socio-demographic and clinical perspective, the present multicenter study 
was carried out. The sample consists of 266 patients, divided in two groups with lifetime 
diagnoses of OCD and OCTD, respectively. OCTD vs OCD patients showed a significant male 
prevalence (68.5% vs 48.5%; p < .001), a higher rate of psychiatric comorbidities (69.4 vs 
50%; p < .001) – mainly with neurodevelopmental disorders (24 vs 0%; p < .001), a lower 
education level and professional status (middle school diploma: 25 vs 7.6%; full-time job 
44.4 vs 58%; p < .001). Moreover, OCTD vs OCD patients showed significantly earlier age 
of OCD and psychiatric comorbidity onsets (16.1 ± 10.8 vs 22.1 ± 9.5 years; p < .001, and 
18.3 ± 12.8 vs 25.6 ± 9.4: p < .001, respectively). Patients with OCTD patients were treated 
mainly with antipsychotic and with a low rate of benzodiazepine (74.2 vs 38.2% and 20.2 
vs 31.3%, respectively; p <  .001). Finally, OCTD vs OCD patients showed higher rates of 
partial treatment response (58.1 vs 38%; p < .001), lower rates of current remission (35.5 vs 
54.8%; p < .001) and higher rates of suicidal ideation (63.2 vs 41.7%; p < .001) and attempts 
(28.9 vs 8.3%; p < .001).
Patients with OCTD report several unfavorable socio-demographic and clinical characteristics 
compared to OCD patients without a history of tic. Additional studies on larger sample are 
needed to further characterize OCTD patients from clinical and therapeutic perspectives. 
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Introduction
Obsessive-Compulsive Disorder (OCD) and Tic Disorder (TD) represent 
disabling, comorbid, chronic and difficult-to-treat conditions, which may 
affect child and adult patients, associated with high levels of burden for 
patients and their relatives. Comorbidity between OCD and TD is fre-
quent  1 2, although it can occur in different phases of patient’s lifespan 
(longitudinally) and not necessarily in the same period (cross-sectional-
ly). Moreover, comorbidity between OCD and TD may be at a subclinical 
level. It has been hypothesized that these disorders and their symptom-
dimensions define a specific subtype of disorder, called Obsessive-Com-
pulsive Tic Disorder (OCTD) 3 4. In the 5th Edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5) 5, OCD has been included 
in the new category of “OC and related disorders”, with the introduction of 
a new “tic-related” specifier. The introduction of this specifier encourages 
new investigations on the epidemiology, clinical presentation, disability 
and therapeutic approach of OCTD 6-10. 
Tics and OCD share some phenomenological, autoimmune and neuro-
Socio-demographic and clinical characterization of patients with Obsessive-Compulsive Tic-related Disorder (OCTD): an Italian multicenter study
149
biological features  11-13 and often co-occur in affected 
individuals and relatives.
It has been recently highlighted that OCTD is more fre-
quently associated with early onset, male gender, sen-
sory phenomena and obsessions of symmetry, aggres-
siveness, hoarding, exactness and sounds, impulsive 
behaviors and ADHD comorbidity 1 2 6-10 14. Patients with 
OCD and comorbid TD accounted for approximately 
15% of the primary OCD sample 15 and they are smok-
ers  16 and have a higher rate of previous suicide at-
tempts 17. 
According to these features, it seems that patients with 
comorbid OCD and TD have a more severe phenotype 
of the disorder, in terms of treatment-resistance, re-
duced quality of life and levels of disability. Moreover, 
OCTD patients report a long delay to diagnosis, a high 
level of functional impairment caused by OC symptoms, 
a history of multiple treating clinicians and current poly-
pharmacotherapy, with the use of deep brain stimula-
tion in some cases 18. 
In order to define socio-demographic and clinical char-
acteristics of patients with OCTD, the present multi-
center study has been conducted, including a sample 
of OCTD patients and a sample of OCD patients with 
no history of tic. We hypothesized that OCTD patients 
might exhibit different epidemiologic and clinical char-
acteristics compared to OCD patients with no history 
of tic.
Methods
The recruitment is still ongoing, with a final target sam-
ple of more than 300 OCD patients. 
Patients affected by OCD or OCTD of any gender and 
age were assessed using a novel questionnaire, under 
validation, developed to better characterize OCTD pa-
tients. The questionnaire is composed of 35 questions 
assessing the following areas: 1) prevalence of OCTD; 
2) patient’s main socio-demographic features (i.e., age, 
gender, occupation, level of education, marital status); 
3) clinical history (i.e., age at OCD onset, age at TD 
onset, presence of other psychiatric comorbidities and 
age at comorbidities’ onset, family history, OCD dura-
tion of untreated illness - DUI); 4) perceived quality of 
life, course of illness, current psychotherapy and psy-
chopharmacological therapies, treatment response, 
presence of past/current suicidal ideation or attempt.
Statistical analysis
In order to compare clinical and demographic features 
of OCD patients with and without comorbid TD, Pear-
son Chi-squared tests and Student’ t-test were used, as 
appropriate. All analyses were performed using SPSS 
24 for Windows software (Chicago, IL) with the level of 
statistical significance put at 0.05.
Results
The current sample includes 266 adult patients with 
OCD with and without comorbid TD of either gender 
and any age, afferent to different psychiatric depart-
ments across Italy, distributed as follows: 47 from Poli-
clinico Hospital, Milan; 30 from Galeazzi Hospital, Mi-
lan; 16 from San Paolo Hospital, Milan; 60 from Istituto 
di Psicopatologia, Rome; 30 from Rita Levi Montalcini 
Department of Neuroscience, Turin; 24 from Depart-
ment of Neuroscience, Florence; 26 from Teramo Hos-
pital; 33 from Department of Biomedical and Neuro-
motor Sciences, Alma Mater Studiorum University of 
Bologna. 
Main demographic and clinical variables of the study 
sample are reported in Table I.
In the OCD participating centers, the prevalence of 
OCD ranges between 5-25%, while in the Tic/Tourette 
Center the prevalence of OCD is more than 90%.
The sample consists of 132 (51.5%) OCD patients with-
out TD and 124 (48.5%) OCTD patients. 
OCTD patients are mainly male (OCTD: 68.5 vs OCD: 
48.5; p < .001), younger (OCTD: 30.7 ± 13.8 vs OCD: 
37.4 ± 13.4; p < .001), with a low level of education and 
of professional status (OCTD: middle school diploma: 
25 vs OCD: 7.6%; OCTD: full-time job 44.4 vs OCD: 
58%; p < .001) compared to OCD patients (Figs. 1-2).
OCTD patients report a significantly earlier age at OCD 
onset (OCTD: 16.1 ± 10.8 vs OCD: 22.1 ± 9.5 years; 
p < .001), a earlier age of comorbidities’ onset (OCTD: 
18.3 ± 12.8 vs OCD: 25.6 ± 9.4: p < .001), a higher rate 
of psychiatric comorbidities (OCTD: 69.4 vs OCD: 50%; 
p  <  .001) mainly with neurodevelopmental disorders 
(e.g. ADHD), compared to OCD patients. 
As regards pharmacological treatment (Tab. II), OCTD 
patients are most frequently treated with D2 antago-
nist and/or D2, 5-HT2 antagonist treatment compared 
to OCD patients (p  <  .001). OCTD patients report 
lower rates of current remission of symptoms (35.5 
vs 54.8%; p < .001), higher rates of suicidal ideation 
(63.2 vs 41.7%; p < .001) and suicide attempts (28.9 
vs 8.3%; p <  .001), and higher rates of partial treat-
ment response (58.1 vs 38%; p < .001) compared to 
OCD patients.
Discussion
The first relevant finding of our study is the different 
prevalence of OCD and TD in primary OCD vs Tic/To-
urette centers, indicating that Tic and Tic-related speci-
fier is a consistent phenotype in primary OCD patients, 
but in primary TD/Tourette patients, comorbid OCD 
seems the rule rather than the exception 19 20. Our find-
ings confirm that OCTD defines a more severe pheno-
type of OCD compared with OCD without Tic. We found 
a significantly higher male prevalence in the OCTD 
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group, compared to the OCD without TD group. This 
finding seems to be consistent with most of the current 
literature indicating a male preponderance in tic-related 
OCD  7. As regards the onset of first OCD symptoms, 
we found an earlier onset in OCTD patients compared 
to OCD patients without tics. This finding is in line with 
Diniz et al. 21, which found that patients with OCD and 
Tic Symptoms (TS) presented an earlier age at onset 
compared to OCD patients without tics. 
Moreover, we found that psychiatric comorbidity rate 
was significantly higher in OCTD patients compared to 
the group without TD. OCTD patients showed a signifi-
cantly higher comorbidity with neurodevelopmental dis-
orders, such as attention-deficit/hyperactivity disorder 
and autism spectrum disorders. This finding is consis-
tent with previous research from Coffey and colleagues 
and Lewin and coauthors, showing a higher prevalence 
of comorbid neurodevelopmental disorders both in chil-
dren and adults with OCTD, when compared to OCD 
patients without TD 19 22.
Previous studies and ICOCS reports showed significant 
positive correlation between the number of comorbid 
DSM-IV-TR Axis I-disorders and OCD severity and du-
ration of illness 15 23. In the present study, the OCTD sub-
group showed an overall higher severity of illness. This 
is the first study exploring socio-demographic features 
of OCTD patients; in particular, OCTD patients showed 
significantly lower rates of university/master education 
and full-time employment compared to OCD patients 
without TD. It should be that the burden of OCTD se-





M:F 64 (48.5%): 68 (51.5%) 85 (68.5%)*: 39 (31.5%)
Family history 74 (56.5%) 79 (63.7%)
Psychiatric comorbidity 66 (50%) 86 (69.4%)*
Affective disorders 39 (37.9%) 27 (27%)
Psychosis 3 (2.9) 2 (2%)
Anxiety disorders 11 (10.7%) 16 (16%)
Personality
disorders
5 (4.9%) 2 (2%)
Neurodevelopmental disorders 0 24 (24%)*
Eating disorders 2 (3.9%) 0
Poly-comorbidity 4 (3.9%) 11 (11%)
Age 37.4 ± 13.4 30.7 ± 13.8*
Age at OCD onset 22.1 ± 9.5 16.1 ± 10.8 *
Age at TIC onset - 12 ± 9.5
Age at comorbity onset 25.6 ± 9.4 18.3 ± 12.8 *
DUI (months) 64.6.4 ± 88.6 60.8 ± 77.8
Married 49 (37.4%) 36 (29%)
Professional status
 
Unemployed 32 (24.4%) 22 (17.7%)
Full-time 76 (58%)* 55 (44.4%)
Part-time 2 (1.5%) 3 (2.4%)
Retired 6 (4.6%) 4 (3.2%)
Student 15 (11.5%) 40 (32.3%)*
Level of education Middle school diploma 10 (7.6%) 31 (25%)*
High school diploma 67 (51.1%) 62 (50%)
University degree/master degree 54 (41.2%)* 31 (25%)
Values for categorical and continuous variables are expressed as N (%) and mean ± SD, respectively
* p < .001
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FIGURE 1. Summary of categorical variables in OCD vs OCTD patients.
** p < .001





Previously treated in other medical centers 89 (67.9%) 84 (68.3%)
Psychotherapy 85 (64.9%) 76 (61.3%)
Psychopharmacological treatment (current) 126 (96.2%) 122 (98.4%)
Antidepressants 119 (90.8%) 112 (90.3%)
D2 antagonist and/or D2, 5-HT2 antagonist treatment 50 (38.2%)* 92 (74.2%)*
Mood stabilizers 32 (24.4%) 29 (23.4%)
Gaba receptor agonist 41 (31.3%)* 25 (20.2%)
Family involvement 60 (46.2%) 44 (35.5%)
Worsened quality of life 65 (50%) 54 (43.5%)
Current treatment responders 70 (53.8%)* 45 (36.3%)
Current partial treatment responders 49 (38%)* 72 (58.1%)*
Residual tic symptoms - 35 (36.5%)
Residual OCD symptoms 48 (82.8%)* 60 (62.5%)*
Residual OCD + tic - 27 (27.8%)
Current remission 69 (54.8%)* 44 (35.5%)*
Past remission 43 (37.4%)* 72 (60%)*
Treatment resistance 17 (13.2%) 22 (17.9%)
Suicidal thoughts 20 (41.7%)* 24 (63.2%)*
Suicide attempts 4 (8.3%)* 11 (28.9%)*
Values for categorical variables are expressed as N (%)
* p < .001
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al assessment design. Further follow-up studies are need-
ed to better characterize long-term course of OCTD pa-
tients, their functional impairment and treatment response. 
Conclusions
Based on the present findings, a tailored, personalized 
and multidisciplinary treatment seems a priority in the 
management of OCTD patients, given their early onset 
and long-term disabling course. 
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